SCHEMBL24399289

SCHEMBL24399289

BC1(O)C(Cn2cc(-c3ncnc4[nH]ccc34)cn2)C(O)(O)C(B)(B)C1(B)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 19/20 0.51
HDAC6 Q9UBN7 12/20 0.51
HDAC1 Q13547 9/20 0.50
JAK1 P23458 9/20 0.49
JAK3 P52333 7/20 0.49
TYK2 P29597 5/20 0.49
HDAC3 O15379 2/20 0.49
HDAC2 Q92769 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
NCOR2 Q9Y618 2/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
DAPK3 O43293 2/20 0.42
PAK4 O96013 2/20 0.42
ABL1 P00519 2/20 0.42
RET P07949 2/20 0.42
LTK P29376 2/20 0.42
CSNK1A1 P48729 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19578571 0.86 JAK2 (0.53) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL24053067 0.77 JAK2 (0.55) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL27435175 0.76 JAK2 (0.50) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL24399172 0.76 JAK2 (0.50) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL24399312 0.76 JAK2 (0.50) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL12799123 0.76 JAK2 (0.54) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL12799122 0.76 JAK2 (0.54) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL10315626 0.75 JAK2 (0.59) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL13774665 0.74 JAK2 (0.61) JAK2HDAC6HDAC1JAK1JAK3
SCHEMBL28340692 0.74 JAK2 (0.61) JAK2HDAC6HDAC1JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022094133-A9 REGIMENS FOR THE TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS SUN PHARMACEUTICAL INDUSTRIES, INC. (US) 2023-05-19 WO disclosed
WO-2022094133-A1 REGIMENS FOR THE TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS CONCERT PHARMACEUTICALS, INC. (US) 2022-05-05 WO disclosed